Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-06-07FDA Approved: VILAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals, Inc.)
The FDA approved Teva's supplemental application for vilazodone hydrochloride (generic vilazodone) under ANDA 208212.
-
FDA approval · 2023-06-07FDA Approved: QUETIAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for a generic quetiapine product from Macleods Pharmaceuticals Limited.
-
FDA approval · 2023-06-05FDA Approved: QUETIAPINE — Supplemental Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare Inc.'s supplemental application for quetiapine (ANDA 202152), granting approval of a generic quetiapine p…
-
FDA approval · 2023-05-30FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approves a supplemental application for quetiapine fumarate submitted by Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2023-05-19FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Amitriptyline hydrochloride from Rising Pharma Holdings, Inc. under an Original Application (generic) for the treatment of majo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-05-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved a generic version of venlafaxine hydrochloride from Granules Pharmaceuticals Inc. via an Original Application (ANDA), a generic…
-
FDA approval · 2023-05-11FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for quetiapine fumarate submitted by BluePoint Laboratories. This action approves a modification to …
-
FDA approval · 2023-05-11FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for quetiapine fumarate filed by Sun Pharmaceutical Industries.
-
FDA approval · 2023-05-11FDA Approved: QUETIAPINE EXTENDED RELEASE — Supplemental Application (ACI Healthcare USA, Inc.)
FDA approves a supplemental application for a generic Quetiapine Extended Release product from ACI Healthcare USA, expanding access to the e…
-
FDA approval · 2023-05-11FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for quetiapine fumarate from Aurobindo Pharma Limited, enabling generic production under an Abbrevia…
-
FDA approval · 2023-05-11FDA Approved: QUETIAPINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA granted a supplemental approval for Quetiapine (generic) from Ascend Laboratories, LLC, approving an additional application for this…
-
FDA approval · 2023-05-10FDA Approved: REXULTI — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for Rexulti (brexpiprazole) submitted by Otsuka America Pharmaceutical, Inc., resulting in chang…
-
FDA approval · 2023-05-02FDA Approved: DULOXETINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application from Actavis Pharma, Inc. for duloxetine under ANDA 090776, granting approval for a supplemental cha…
-
FDA approval · 2023-05-02FDA Approved: DULOXETINE — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved a supplemental application for duloxetine submitted by Solco Healthcare US, LLC (ANDA206653), authorizing a change related …
-
FDA approval · 2023-05-01FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for imipramine hydrochloride from Strides Pharma Science Limited, enabling continued marketing o…
-
FDA approval · 2023-05-01FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Par Health USA, LLC)
FDA announces a supplemental approval for a generic fixed-dose combination of olanzapine and fluoxetine by Par Health USA, LLC under ANDA 07…
-
FDA approval · 2023-05-01FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for imipramine hydrochloride by Strides Pharma Science Limited, a generic antidepressant.
-
FDA approval · 2023-05-01FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's original application for Amitriptyline Hydrochloride (generic) under ANDA, authorizing its marketing in th…
-
FDA approval · 2023-04-20FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Ingenus Pharmaceuticals, LLC)
FDA approved a supplemental application for quetiapine fumarate from Ingenus Pharmaceuticals, LLC, marking an additional approval/modificati…
-
FDA approval · 2023-04-19FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for quetiapine fumarate from Aurobindo Pharma Limited, authorizing a generic version under an ANDA.
-
FDA approval · 2023-04-19FDA Approved: QUETIAPINE — Supplemental Application (Solco Healthcare U.S., LLC)
FDA approved a supplemental application for quetiapine from Solco Healthcare U.S., LLC to authorize a generic version of the drug for the U.…
-
FDA approval · 2023-04-12FDA Approved: VENLAFAXINE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s original generic application for venlafaxine. The approval covers generic venlafaxine for the treatmen…
-
FDA approval · 2023-04-06FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for escitalopram oxalate from Quallent Pharmaceuticals Health LLC, authorizing a generic version of …
-
FDA approval · 2023-04-03FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved Novadoz Pharmaceuticals LLC's original application for doxepin hydrochloride (generic). The approval supports the generic produ…
-
FDA approval · 2023-03-31FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for Granules Pharmaceuticals' sertraline hydrochloride generic product, enabling its marketing in th…